Veterinary and Comparative Oncology

Papers
(The TQCC of Veterinary and Comparative Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Identification of potential plasma protein biomarkers for feline pancreatic carcinoma by liquid chromatography tandem mass spectrometry141
Issue Information17
Issue Information16
Issue Information15
Visualizing the cancer stem‐like properties of canine tumour cells with low proteasome activity14
Abstracts14
Author Index14
Issue Information13
13
Evaluation of serum interleukin 2 receptor and beta‐2‐microglobulin as prognostic factors for canine lymphoma: A pilot study13
Diagnostic accuracy of optical coherence tomography for surgical margin assessment of feline injection‐site sarcoma12
Editorial12
Facilitating stakeholder involvement in Comparative Oncology research: A qualitative analysis of key stakeholder opinions and perceptions11
Description and efficacy of a response‐based “QUAD” cyclical hypofractionated palliative‐intent radiation protocol in dogs with macroscopic solid tumours: 108 cases11
High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours10
10
Multi‐institutional retrospective study of canine foot pad malignant melanomas: 20 cases10
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma9
Canine presumed glial brain tumours treated with radiotherapy: Is there an inferior outcome in tumours contacting the subventricular zone?9
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy9
There and back again: Translating adoptive cell therapy to canine cancer and improving human treatment9
Effects of a high‐protein, increased‐fibre, dry diet supplemented with omega‐3 fatty acids on quality of life in dogs undergoing chemotherapy9
Ultrasound‐guided core needle biopsy in dogs with thyroid carcinoma9
8
Canine squamous cell carcinoma: Electrochemotherapy association with surgery and correlation with overall survival8
BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006–2019)8
Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours8
Sodium iodide symporter immunolabelling as a predictor of clinical iodide uptake in canine thyroid carcinoma: A preliminary study8
Characterizing the metabolic role of STAT3 in canine osteosarcoma7
Characterization and function of extracellular vesicles in a canine mammary tumour cell line: Ultracentrifugation versus size exclusion chromatography7
Feasibility and safety of whole lung irradiation in the treatment of canine appendicular osteosarcoma7
Evaluation of the anti‐tumour activity of Coriolus versicolor polysaccharopeptide (I'm‐Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma7
Risk of bladder cancer and lymphoma in dogs is associated with pollution indices by county of residence7
Risk factors influencing death prior to discharge in 302 dogs undergoing unilateral adrenalectomy for treatment of primary adrenal gland tumours7
A retrospective comparison of first and second opinion histopathology with patient outcomes in veterinary oncology cases (2011–2019)7
Inter‐pathologist agreement on diagnosis, classification and grading of canine glioma7
Timely adjuvant chemotherapy improves outcome in dogs with non‐metastatic splenic hemangiosarcoma undergoing splenectomy7
Abstracts7
Treatment of feline intermediate to high‐grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017–2021)6
Comparison of response assessment in veterinary neuro‐oncology and two volumetric neuroimaging methods to assess therapeutic brain tumour responses in veterinary patients6
Comparison of Three Chemotherapy Protocols With Electrochemotherapy for the Treatment of Feline Cutaneous Squamous Cell Carcinoma6
Targeting ATR Kinase as a Strategy for Canine Lymphoma and Leukaemia Treatment6
Stereotactic body radiation therapy as an alternative to adrenalectomy for the treatment of pheochromocytomas in 8 dogs6
Comparative gene expression study highlights molecular similarities between triple negative breast cancer tumours and feline mammary carcinomas6
Patterns of metastatic progression and association with clinical outcomes in canine osteosarcoma: A necropsy study of 83 dogs6
Isolation of Tumour‐Derived Extracellular Vesicles From the Plasma of Dogs Affected by Intracranial Tumours Showing Heterologous and Cross‐Species Tropism: A Pilot Study6
Sentinel lymph node mapping in canine mast cell tumours using a preoperative radiographic indirect lymphography: Technique description and results in 138 cases6
Distribution of Inflammatory Infiltrate in Feline Mammary Lesions: Relationship With Clinicopathological Features6
Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma6
Stromal Expression Profiling Reveals Immune‐Driven Adaption to Malignancy in Canine Melanoma Subtypes5
Procarbazine, prednisolone and cyclophosphamide oral combination chemotherapy protocol for canine lymphoma5
The role of toceranib phosphate in dogs with non‐mast cell neoplasia: A systematic review5
Clinical Utility of Circulating Cell‐Free DNA as a Liquid Biopsy in Cats With Various Tumours5
5
Impact of 10% Dose Reductions and Duration of Treatment Delays in the Management of Chemotherapy‐Induced Neutropenia in Dogs Treated With Common Chemotherapy Protocols: A Single‐Centre Experience5
A retrospective analysis of 11 dogs with surface osteosarcoma5
Extracellular heat shock protein 70 levels in tumour‐bearing dogs and cats treated with radiation therapy and hyperthermia5
A Retrospective Study Evaluating the Outcomes of Conventionally Fractionated Radiation Therapy as a Treatment for Infiltrative Lipomas in Twenty‐One Dogs5
Ovariectomy reduces the risk of tumour development and influences the histologic continuum in canine mammary tumours5
Peritumoral Edema in Canine Extra‐Axial Brain Tumours: Effect of Steroids5
Long‐term survival of dogs with stage 4 oral malignant melanoma treated with anti‐canine PD‐1 therapeutic antibody: A follow‐up case report5
Electrochemotherapy in dogs and cats–A review5
Lymphotropic nanoparticle magnetic resonance imaging for diagnosing metastatic lymph nodes in dogs with malignant head and neck tumours5
Surgical and oncologic outcomes in dogs with malignant peripheral nerve sheath tumours arising from the brachial or lumbosacral plexus5
Stereotactic Radiation Therapy Planning, Dose Prescription and Delivery in Veterinary Medicine: A Systematic Review on Completeness of Reporting and Proposed Reporting Items5
Cyclical 10‐day dosing of melphalan for canine multiple myeloma4
Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain4
Establishment of a new cell line of canine inflammatory mammary cancer: IMC‐1184
Pre‐operative neoadjuvant vinblastine‐prednisolone in canine mast cell tumours: A single‐centre retrospective cohort study4
Practice patterns about the role of palliation in veterinary surgical oncology4
Staging canine patients with appendicular osteosarcoma utilizing fluorine‐18 fluorodeoxyglucose positron emission tomography/computed tomography compared to whole body computed tomography4
A multi‐institutional epidemiologic study evaluating environmental risk factors for feline oral squamous cell carcinoma4
Mastocytosis in the skin in dogs: A multicentric case series4
Issue Information4
Local tumour nanoparticle thermal therapy: A promising immunomodulatory treatment for canine cancer4
Descriptive analysis of haemangiosarcoma occurrence in dogs enrolled in the Golden Retriever lifetime study4
Mass spectrometric‐based assessment of the serum kappa to lambda immunoglobulin light chain ratio (κ:λ) in dogs with immunoglobulin secretory diseases4
Author Index4
Safety and feasibility of short course pre‐operative radiation therapy followed by surgical excision for canine solid tumours4
Leading the pack: Best practices in comparative canine cancer genomics to inform human oncology4
Antioxidant 1 copper chaperone gene expression and copper levels in dog osteosarcoma patients3
Outcome of dogs with bone marrow suppression secondary to Sertoli cell tumour3
Immunohistochemical and transcriptomic characterization of T and myeloid cell infiltrates in canine malignant melanoma3
Prophylactic Antimicrobials for Prevention of Febrile Neutropenia in Tumour‐Bearing Dogs Treated With Lomustine3
Blood biomarkers for canine cancer, from human to veterinary oncology3
Evaluation of the therapeutic potential of masitinib and expression of its specific targets c‐Kit, PDGFR‐α, PDGFR‐β, and Lyn in canine prostate cancer cell lines3
Outcome of dogs treated with chemotherapy for mesothelioma: A retrospective clinical study on 40 cases and a literature review3
SLUG is upregulated and induces epithelial mesenchymal transition in canine oral squamous cell carcinoma3
Immunohistochemical Expression of Programmed Death‐Ligand 1 and Cytotoxic T‐Lymphocyte Antigen‐4 in Canine Cutaneous Mast Cell Tumours3
Regulation of programmed death ligand 1 expression by interferon‐γ and tumour necrosis factor‐α in canine tumour cell lines3
Expression and therapeutic targeting of BMI1 in canine gliomas3
Developing a translational murine‐to‐canine pathway for anIL‐2/agonistanti‐CD40antibody cancer immunotherapy3
Efficacy and adverse events of continuousl‐asparaginase administration for canine large cell lymphoma of presumed gastrointestinal origin3
Oncolytic effect of Newcastle disease virus is attributed to interferon regulation in canine mammary cancer cell lines3
Outcomes of Stereotactic Radiation Therapy Versus Fractionated Radiation Therapy in 44 Dogs With Pituitary Masses: A Multi‐Institutional Retrospective Study (2016–2022)3
Evaluating the relevance of surgical margins. Part one: The problems with current methodology3
Canine anal sac gland carcinoma with regional lymph node metastases treated with sacculectomy and lymphadenectomy: Outcome and possible prognostic factors3
Correlation between computed tomography and histological evaluation of nodal metastasis in dogs with mast cell tumours3
Correction to: Retrospective analysis of outcome and prognostic factors of subcutaneous mast cell tumours in dogs undergoing surgery with or without adjuvant treatment3
Standardisation of canine meningioma grading: Inter‐observer agreement and recommendations for reproducible histopathologic criteria3
Lymphoid Aggregates in Canine Cutaneous and Subcutaneous Sarcomas: Immunohistochemical and Gene Expression Evidence for Tertiary Lymphoid Structures3
Risk factors associated with the onset of lomustine‐induced neutropenia in tumour‐bearing dogs3
Combining radiation therapy with zoledronate for the treatment of osteo‐invasive feline oral squamous cell carcinoma3
Characterization of the dissemination of canine cancer misinformation on YouTube3
Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping3
Novel surgical approach to neoplastic lesions in the distal part of the urethra: A pilot cadaver study comparing open and hybrid techniques3
Liquid biopsy can detect BRCA2 gene variants in female dogs with mammary neoplasia3
KIT mutations in mast cell tumours from cheetahs (Acinonyx jubatus) and domestic cats (Felis catus)3
0.13247489929199